Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
Healthcare
$18.31 +0.58%
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
52W Low $14.85High $23.00
Volume 0.68M
Average 0.41M
SPTX Other Non-current Assets
Long-term assets not reported separately.
No reported Other Non-current Assets figures are available to summarize.
Other Non-current Assets history
Currency unavailable · from the balance sheet
No Other Non-current Assets data reported for this period type.
Other Non-current Assets vs competitors
How SPTX compares with its peers on the latest reported figures
SPTX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $10.82M USD | +7.6% | -0.9% | 2.5% | |
| Mar 2026 | $2.46M USD | +125.2% | — | 0.9% | |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $1.06M USD | +400.9% | — | 0.2% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $312K USD | +7700.0% | +25.7% | 0.1% |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $53K USD | — | -76.6% | 0.0% |
| Mar 2026 | $36K USD | -98.9% | -36.8% | 0.0% | |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $0 USD | -100.0% | — | 0.0% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | +66.4% | -18.8% | 0.1% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.